ADVAIR HFA 115 ug/1 (Fluticasone Propionate and Salmeterol Xinafoate AEROSOL, METERED) 115 ug/1

ADVAIR HFA 115 ug/1 is a combination inhaler containing fluticasone propionate and salmeterol xinafoate. It is commonly used for managing asthma and chronic obstructive pulmonary disease (COPD). This metered aerosol helps control and prevent symptoms like wheezing and shortness of breath.

Strength

115 ug/1

Pack Size

1 INHALER in 1 CARTON (0173-0716-20) / 120 AEROSOL, METERED in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ADVAIR HFA 115 ug/1 is primarily used for the maintenance treatment of asthma and COPD. It combines an inhaled corticosteroid (fluticasone propionate) and a long-acting beta-agonist (salmeterol xinafoate) to reduce inflammation and relax airway muscles. This combination helps manage symptoms such as wheezing, coughing, and shortness of breath, making it easier to breathe.

Side Effects

Common effects of ADVAIR HFA 115 ug/1 may include throat irritation, hoarseness, and a dry mouth. Some users might experience headaches, tremors, or a fast heartbeat. These effects vary among individuals and typically subside as the body adjusts to the medication. Always consult a healthcare provider if side effects are persistent or severe.

Precautions & Warnings

ADVAIR HFA 115 ug/1 should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of throat irritation and fungal infections. Avoid sudden discontinuation without medical advice, as this could worsen symptoms. Keep the inhaler clean and store it at room temperature, away from moisture and heat.

Avoid Interactions

ADVAIR HFA 115 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, avoid using other inhaled medications unless directed by a healthcare professional.

Frequently Asked Questions

ADVAIR HFA 115 ug/1 is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

Use ADVAIR HFA 115 ug/1 as directed by your healthcare provider. Typically, it is inhaled through the mouth, and you should rinse your mouth afterward.

Common side effects may include throat irritation, hoarseness, dry mouth, headaches, tremors, and a fast heartbeat.

Do not stop using ADVAIR HFA 115 ug/1 suddenly without consulting your healthcare provider, as this could worsen your symptoms.

Store ADVAIR HFA 115 ug/1 at room temperature, away from moisture and heat. Keep the inhaler clean and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.